Clinical Trial Update: ADO-5030 in Bronchoconstriction Challenge, Phase 1b [Phase 1]

View source ↗

Summary

ADO-5030 is set to enter Phase 1b bronchoconstriction challenge studies for asthma, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ADO-5030

Snippet

Sponsor: Adovate | Conditions: Asthma (Diagnosis) | Phase 1 | Status: NOT_YET_RECRUITING